491000 — Livsmed Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩2tn
- KR₩2tn
- KR₩27bn
Annual cashflow statement for Livsmed, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -57,021 | -25,585 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 38,063 | 4,470 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -6,800 | -8,196 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Other Liabilities | ||
| Net Change in Other Assets & Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -24,723 | -27,664 |
| Capital Expenditures | -2,494 | -4,455 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | -32,529 | 30,897 |
| Sale of Fixed Assets | ||
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -35,023 | 26,442 |
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 52,884 | 10,170 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -6,892 | 8,797 |